Vitamin A Retinyl Acetate Encyclopedia — Scientific Background

What Is Retinyl Acetate?

Retinyl acetate (CAS 127-47-9), also known as vitamin A acetate or all-trans-retinyl acetate, is the acetate ester of retinol (vitamin A). It is chemically characterized by the molecular formula C₂₂H₃₂O₂ and a molecular weight of 328.49 g/mol. The compound occurs as a pale yellow crystalline powder or supercooled liquid with a melting point of 57–58°C. Retinyl acetate is the most stable ester form of vitamin A, used extensively in dietary supplements, food fortification, and pharmaceutical formulations.

Physiological Functions of Vitamin A

Vitamin A is an essential fat-soluble micronutrient required for numerous physiological processes:

• Vision — Vitamin A is essential for the visual cycle, particularly for the formation of rhodopsin, the light-sensitive pigment in the retina

• Immune Function — Vitamin A supports the normal development and function of immune cells, including T lymphocytes and neutrophils

• Cellular Differentiation — Retinoic acid, the active metabolite of vitamin A, regulates gene expression and cellular differentiation

• Skin Health — Vitamin A promotes skin cell turnover and maintains epithelial tissue integrity

• Reproduction — Vitamin A is required for normal reproductive function

• Growth and Development — Vitamin A is essential for normal growth and bone development

Mechanisms of Action

Visual Cycle

Vitamin A is essential for the visual cycle. Retinal, the aldehyde form of vitamin A, combines with opsin to form rhodopsin, the light-sensitive pigment in rod cells. When light strikes rhodopsin, the retinal undergoes isomerization from 11-cis to all-trans, triggering a signal cascade that results in visual perception.

Gene Expression Regulation

Retinoic acid, the active metabolite of vitamin A, acts as a ligand for nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), regulating the transcription of numerous target genes involved in cellular differentiation, proliferation, and apoptosis.

Immune Function Modulation

Vitamin A supports both innate and adaptive immunity. It is essential for the normal development and function of immune cells, including T lymphocytes and neutrophils, and plays a critical role in mucosal immunity.

Antioxidant Activity

Vitamin A and its precursors exhibit antioxidant activity, scavenging free radicals and protecting cellular membranes from lipid peroxidation.

The Bioavailability Challenge

Despite its essential physiological functions, native retinyl acetate presents significant formulation challenges. The compound is highly susceptible to oxidation, isomerization, and light-induced degradation. Its stability is significantly affected by temperature, oxygen, and light exposure. While retinyl acetate is more stable than retinol, it still degrades over time, particularly under adverse storage conditions.

liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects retinyl acetate from gastric degradation and oxidative stress, and enhances intestinal absorption through lipid-mediated pathways. liposomes remain stable in the stomach and are absorbed intact in the small intestine via M cells, primarily in the duodenum, through endocytosis or membrane fusion.

Liposomal vitamin A Retinyl Acetate

Liposomal encapsulation of retinyl acetate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the retinyl acetate molecule, forming a protective shell that enhances stability, bioavailability, and therapeutic efficacy. This delivery system:

• Achieves encapsulation efficiency greater than 70% for lipophilic compounds

• Provides controlled release (27% in 8 hours) with liposome diameters around 100 nm

• Stabilizes retinoids against gastric and enzymatic degradation

• Exhibits greater stability and diminished toxicity compared to free forms

• Enhances therapeutic efficacy 65-fold and 51-fold for retinoic acid and retinol liposomes, respectively

A study on retinol liposomes demonstrated that liposomes were stable in buffer and serum during 24 hours, and encapsulation prevented retinoic acid from being metabolized over time, maintaining its plasmatic concentration. Retinoic acid liposomes were more efficient at maintaining retinoic acid plasma levels over time than retinoic acid beadlets administered per os.

Clinical Evidence

Leukemia Treatment

Clinical trials in patients suffering from promyelocytic leukemia demonstrated that treatment with retinoic acid liposomes combined with chemotherapy could significantly lead to remission when leukemia was diagnosed early. These results constitute support for more complete studies, although only 12 patients were included in the trial.

Neonatal Pneumonia

A randomized study evaluated intravenously administered liposomal vitamin A in neonatal pneumonia. Thirty neonates with infectious pneumonia were randomized into an intravenous group receiving liposomal vitamin A (330 IU) and an oral group, demonstrating the clinical application of liposomal vitamin A in neonatal care.

Vitamin A Deficiency Prevention

Clinical guidelines recommend vitamin A supplementation in populations at risk of deficiency. For children aged 6–59 months, the WHO recommends periodic vitamin A supplementation, with doses of 100,000 IU (30 mg retinol equivalent) for infants 6–11 months and 200,000 IU (60 mg retinol equivalent) for children 12–59 months, administered every 4–6 months. Oral liquid, oil-based preparations of retinyl Palmitate or retinyl acetate are used for this purpose.

Safety and Regulatory

Vitamin A is generally well tolerated at recommended intake levels. The Tolerable Upper Intake Level (UL) for preformed vitamin A is 3,000 μg RAE/day (10,000 IU) for adults. The critical adverse health effect of excess intake of vitamin A is teratogenicity, which is the basis for the UL. High oral doses of vitamin A as retinyl acetate (>10,000 IU daily long-term) are teratogenic and should be avoided during pregnancy. The EFSA Panel upheld the UL of 3,000 μg RAE per day (approximately 10,000 IU) for preformed vitamin A.

Regulatory status varies by region:

• United States — Vitamin A acetate is regulated as a dietary supplement ingredient. It is Generally Recognized As Safe (GRAS) for use in food and dietary supplements.

• European Union — Retinyl acetate complies with the current "Vitamin A concentrate (powder form), synthetic" Ph.Eur. monograph.

• Canada — Oral dosage forms providing not greater than 10,000 IU/day of vitamin A activity are permitted as Natural Health Products. Above 10,000 IU/day, vitamin A is classified as a prescription drug.

• Global Standards — Retinyl acetate is monographed in the USP, European Pharmacopoeia, and Food Chemicals Codex. It is widely used in food fortification programs worldwide.

Liposomal Vitamin A Retinyl Acetate 2 Million IU is widely commercialized as a dietary supplement ingredient and food fortificant. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

199$/KG

169$/KG